We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$511M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
224
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17% |
| 2 | Technology | 14.79% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Q2 Holdings
QTWO
$3.8B
| $74.9M | 0.18% |
949,760
-59,984
| -6% | -$4.96M |
|
127
Biogen
BIIB
$31B
| $74.7M | 0.18% |
320,719
+54,821
| +21% | +$12.8M |
|
128
Johnson & Johnson
JNJ
$644B
| $74.3M | 0.18% |
574,534
-25,406
| -4% | -$3.35M |
|
129
LivaNova
LIVN
$4.47B
| $73.7M | 0.18% |
998,685
+122,677
| +14% | +$9.45M |
|
130
RPM International
RPM
$13.9B
| $73.5M | 0.18% |
1,068,793
-56,578
| -5% | -$3.75M |
|
131
Minerva Neurosciences
NERV
$192M
| $73.4M | 0.18% |
1,183,240
+232,579
| +24% | +$13.2M |
|
132
Global Payments
GPN
$23.9B
| $72.9M | 0.18% |
458,190
+100,515
| +28% | +$16.4M |
|
133
Trip.com Group
TCOM
$29.2B
| $72.5M | 0.18% |
2,476,913
+915,355
| +59% | +$32.2M |
|
134
KLA
KLAC
$225B
| $72.5M | 0.18% |
4,549,710
+3,781,630
| +492% | +$52.9M |
|
135
DuPont de Nemours
DD
$18.6B
| $71.7M | 0.18% |
800,637
+245,619
| +44% | +$21.6M |
|
136
Wintrust Financial
WTFC
$10.8B
| $70.2M | 0.17% |
1,086,166
-102,825
| -9% | -$6.82M |
|
137
TotalEnergies
TTE
$193B
| $69.1M | 0.17% |
1,329,543
-416,222
| -24% | -$21.6M |
|
138
Walmart Inc
WMT
$906B
| $68.6M | 0.17% |
1,735,107
+89,391
| +5% | +$3.37M |
|
139
AMN Healthcare
AMN
$1.35B
| $68M | 0.17% |
1,180,665
+45,993
| +4% | +$2.55M |
|
140
Steris
STE
$22.8B
| $67.7M | 0.17% |
468,493
-145,568
| -24% | -$21.8M |
|
141
Travelers Companies
TRV
$82.3B
| $67.5M | 0.17% |
454,163
-180,478
| -28% | -$26.8M |
|
142
Vail Resorts
MTN
$5.66B
| $67M | 0.16% |
294,284
+13,000
| +5% | +$3.07M |
|
143
AptarGroup
ATR
$8.63B
| $66.9M | 0.16% |
564,782
-79,572
| -12% | -$9.63M |
|
144
Kirby Corp
KEX
$7.14B
| $66.9M | 0.16% |
813,732
-35,876
| -4% | -$2.75M |
|
145
Newmont
NEM
$94.8B
| $65.6M | 0.16% |
1,729,555
+478,391
| +38% | +$18.6M |
|
146
Vertex Pharmaceuticals
VRTX
$124B
| $64.6M | 0.16% |
381,276
+56,546
| +17% | +$10M |
|
147
Agnico Eagle Mines
AEM
$70.8B
| $64.4M | 0.16% |
1,201,800
+275,200
| +30% | +$15.6M |
|
148
Capital One
COF
$130B
| $64.3M | 0.16% |
706,772
-56,274
| -7% | -$5.06M |
|
149
Merck
MRK
$324B
| $64M | 0.16% |
797,373
-76,272
| -9% | -$6.11M |
|
150
Lockheed Martin
LMT
$133B
| $63.9M | 0.16% |
163,707
-41,643
| -20% | -$15.7M |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 224 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 224 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.